Glutamine/arginine site-unedited GluA2 mRNA in cerebrospinal fluid as a biomarker for amyotrophic lateral sclerosis

J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):876-878. doi: 10.1136/jnnp-2023-331164. Epub 2023 May 3.

Takashi Hosaka^{1

2

3}, Hiroshi Tsuji¹, Makoto Terada^{1

2

3}, Yasushi Tomidokoro¹, Akiko Ishii¹, Kiyotaka Nakamagoe¹, Kazuhiro Ishii¹, Hiroo Terashi⁴, Hitoshi Aizawa^{4

5}, Akira Tamaoka¹, Shin Kwak^{6

5}

¹ Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
² University of Tsukuba Hospital/Jichi Medical University Joint Ibaraki Western Regional Clinical Education Center, Chikusei, Japan.
³ Internal Medicine, Ibaraki Western Medical Center, Chikusei, Japan.
⁴ Department of Neurology, Tokyo Medical University, Tokyo, Japan.
⁵ Department of Molecular Neuropathogenesis (Endowed Chair, GTRI), Tokyo Medical University, Tokyo, Japan.
⁶ Department of Neurology, Tokyo Medical University, Tokyo, Japan kwak@tokyo-med.ac.jp.

No abstract available

Keywords: ALS; CSF.

Publication types